Erratum to: Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapy

被引：0
|
作者：
Vincenzo Bruzzese
Angelo Zullo
Andrea Picchianti Diamanti
Lorenzo Ridola
Roberto Lorenzetti
Cinzia Marrese
Palma Scolieri
Vincenzo De Francesco
Cesare Hassan
Alberto Migliore
Bruno Laganà
机构：
[1] Ospedale Nuovo Regina Margherita,Medicina Interna, Reumatologia e Gastroenterologia
[2] ‘Sapienza’ University of Rome,Allergy, Clinical Immunology and Rheumatology
[3] S. Andrea University Hospital,Gastroenterology Unit
[4] Sapienza University of Rome “Polo Pontino” Hospital,Gastroenteroolgy Unit
[5] ‘RiUniti’ Hospital,Rheumatology Unit
[6] San Pietro Fatebenefratelli Hospital,undefined
来源：
Internal and Emergency Medicine | 2017年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 141
相关论文
共 50 条
  • [41] The role of vitamin D supplementation in patients with rheumatic diseases
    Bo Abrahamsen
    Nicholas C. Harvey
    [J]. Nature Reviews Rheumatology, 2013, 9 : 411 - 422
  • [42] VITAMIN D RECEPTOR (VDR) FOKI POLYMORPHISM, VITAMIN D AND BMD IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Szymczak-Tomczak, A.
    Krela-Kazmierczak, I.
    Kaczmarek-Rys, M.
    Skrzypczak-Zielinska, M.
    Szalata, M.
    Drweska-Matelska, N.
    Lykowska-Szuber, L.
    Eder, P.
    Michalak, M.
    Dobrowolska, A.
    Slomski, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S443 - S444
  • [43] VITAMIN D RECEPTOR (VDR) BSMI POLYMORPHISM, VITAMIN D AND BMD IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Szymczak-Tomczak, A.
    Krela-Kazmierczak, I.
    Kaczmarek-Rys, M.
    Skrzypczak-Zielinska, M.
    Szalata, M.
    Drweska-Matelska, N.
    Lykowska-Szuber, L.
    Eder, P.
    Michalak, M.
    Dobrowolska, A.
    Slomski, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S446 - S446
  • [44] VITAMIN D RECEPTOR (VDR) APAI POLYMORPHISM, VITAMIN D AND BMD IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Szymczak-Tomczak, A.
    Krela-Kazmierczak, I.
    Kaczmarek-Rys, M.
    Skrzypczak-Zielinska, M.
    Szalata, M.
    Drweska-Matelska, N.
    Lykowska-Szuber, L.
    Eder, P.
    Michalak, M.
    Dobrowolska, A.
    Slomski, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S447 - S447
  • [45] VITAMIN D RECEPTOR (VDR) TAQI POLYMORPHISM, VITAMIN D AND BMD IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Szymczak-Tomczak, A.
    Krela-Kazmierczak, I.
    Kaczmarek-Rys, M.
    Skrzypczak-Zielinska, M.
    Szalata, M.
    Drweska-Matelska, N.
    Lykowska-Szuber, L.
    Eder, P.
    Michalak, M.
    Dobrowolska, A.
    Slomski, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S448 - S448
  • [46] Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases
    Berghea, Florian
    Berghea, Camelia Elena
    Zaharia, Dumitru
    Trandafir, Andreea Iulia
    Nita, Elena Cristina
    Vlad, Violeta Maria
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [47] Prevalence and factors associated with vitamin D deficiency in patients with inflammatory bowel disease on biologic therapies
    Sugrue, K.
    Fitzgerald, D.
    Buckley, M.
    McCarthy, J.
    Farrell, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S113 - S113
  • [48] Biologic targeting in the treatment of inflammatory bowel diseases
    Bosani, Matteo
    Ardizzone, Sandro
    Porro, Gabriele Bianchi
    [J]. BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 77 - 97
  • [49] Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much?
    Hlavaty, Tibor
    Krajcovicova, Anna
    Payer, Juraj
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 (02): : 198 - 209
  • [50] Erratum: Pharmacogenetics: implications for therapy in rheumatic diseases
    Lesley Davila
    Prabha Ranganathan
    [J]. Nature Reviews Rheumatology, 2015, 11 : 258 - 258
12345